Atrial fibrillation patients saw 69% lower risk with common blood thinners
Direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke, according to the randomized SINGLE-AF trial. The benefit was driven mainly by fewer ischemic strokes, with no increase in major bleeding.
This is a short extract from a report by Science Daily. The full text stays with the publisher — follow the link to read it there.
Read at source